[1] Prato G P,Zuccati G,Clauser C.A translational medicine approach to tooth transplantation[J].Journal of Periodontology,2017(0):1-13.
[2] K Bærøe.Translational ethics:an analytical framework of translational movements between theory and practice and a sketch of a comprehensive approach[J].BMC medical ethics,2014,15:71.
[3] Barazzetti G,Hurst S A,Mauron A.Adapting Preclinical Benchmarks for First‐in‐Human Trials of Human Embryonic Stem Cell‐Based Therapies[J].Stem cells translational medicine,2016,5(8):1058-1066.
[4] Petrelli A,Prakken B J,Rosenblum N D.Developing translational medicine professionals:the Marie Sktodowska-Curie action model[J].Journal of Translational Medicine,2016,14(1):329.
[5] Kimmelman J,London A J.Predicting harms and benefits in translational trials:ethics,evidence,and uncertainty[J].PLoS Med,2011,8(3):e1001010.
[6] Hess PG.Risk of tumorigenesis in first- in-human trials of embryonic stem cell neural derivatives:Ethics in the face of long-term uncertainty. Account Res 2009;16:175-198.
[7] Food and Drug Administration. Human cells,tissues,and cellular and tissue-based products (CFR,Title 21,Part 1271).Available at . Human cells,tissues,and cellular and tissue-based products (CFR,Title 21,Part 1271).Available at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcf r/CFR Search.cfm?CFR Part=1271&showFR=1.Accessed July 1,2015.
[8] Food and Drug Administration. Center for Biologics Evaluation and Research (CBER),Guidance for reviewers. Instruction and template for chemistry,manufacturing,and control (CMC) reviewers of human somatic cell therapy investigational new drug applications (INDs). 2003. Available at . Center for Biologics Evaluation and Research (CBER),Guidance for reviewers. Instruction and template for chemistry,manufacturing,and control (CMC) reviewers of human somatic cell therapy investigational new drug applications (INDs). 2003. Available at http://www.fda.gov/OHRMS/DOCKETS/98fr/03d0349gdl.pdf. Accessed July 1,2015.
[9] 单芳,党晋萍,卓选鹏等.论生物样本库研究类论文伦理问题的编辑审查[J].编辑学报,2016(1).
[10] 毛新志.转基因食品安全的伦理透视[J].武汉理工大学学报(社会科学版),2007(1).
[11] Emanuel E J,Wendler D,Grady C.What makes clinical research ethical?[J].Jama,2000, 283(20):2701-2711.
[12] MacKay D. Fair subject selection in clinical research:formal equality of opportunity [J].Journal of Medical Ethics,2016(10).
[13] Ethical and Policy Issues in Research Involving Human Participants[R].U.Sthical and Policy Issues in Research Involving Human Participants[R].U.S.,NBAC.2008.
[14] CIOMS.2002.International ethical guidelines for biomedical research involving human subjects. Geneva:Council for International Organizations of Medical Sciences.
[15] 何怀宏. 公平的正义(解读罗尔斯《正义论》)[M].济南:山东人民出版社,2002.
[16] 牛津高阶英汉双解词典[M]津高阶英汉双解词典[M].香港:牛津大学出版社,2007.
[17] Sands G J,Means P A.Ethical and legal issues in the conduct of cancer clinical trials[M]//Cancer Clinical Trials:Proactive Strategies.Springer US,2007:219-229.
[18] Kimmelman J. The ethics of human gene transfer[J].Nature Reviews Genetics,2008(3).
[19] Marks J H. Expedited industry-sponsored translational research:A seductive but hazardous cocktail?[J].The American Journal of Bioethics,2008(3).
[20] R·K·默顿.十七世纪英国的科学、技术与社会.范岱年等,译.成都:四川人民出版社,1986. |
